Arca
Skip to content
Tools
Tools

TPO: Thyroid peroxidase

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Iodination and coupling of the hormonogenic tyrosines in thyroglobulin to yield the thyroid hormones T(3) and T(4). .

  • Drugs that act on it: 3
  • Approved: 3
  • In phases 1 to 3: 0
  • Sponsors: 2

Who Is On It, and How Far Along

Every drug ChEMBL records acting on TPO, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved3

  • Methimazole
  • Carbimazole
  • Propylthiouracil

Phase 30

    Phase 20

      Phase 10

        The Landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Thyroid peroxidase inhibitor.
        MethimazoleApprovedPfizerSmall moleculeInhibitor—7—
        CarbimazoleApproved—Small moleculeInhibitor—1—
        PropylthiouracilApprovedPH HealthSmall moleculeInhibitor—1Boxed warning

        Open Trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        AI-Based Wearable Monitoring (Glandy HYPER) for Antithyroid Drug Dose Adjustment in Graves' DiseaseMethimazoleNot applicableNot yet recruitingTHYROSCOPE INC.2026-10-05
        Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' DiseaseMethimazolePhase 2Active, not recruitingNorthwell Health2026-01-27
        A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in ChinaMethimazole—RecruitingFirst Hospital of China Medical University2025-06-27
        Prospective Evaluation of OptiThyDoseMethimazole, CarbimazoleNot applicableRecruitingUniversity Children's Hospital Basel2025-03-07
        Somesthesia in Cancer Patients: Variability and Influence on Eating ExperiencePropylthiouracil—Not yet recruitingHospices Civils de Lyon2025-01-31
        A Clinical Study of Hyperthyroidism in ChildrenMethimazole—RecruitingShengjing Hospital2024-08-26
        Iodine Supplementation in Graves' HyperthyroidismMethimazoleNot applicableNot yet recruitingShandong Provincial Hospital2024-08-06
        Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' DiseaseMethimazolePhase 4RecruitingThe First Affiliated Hospital with Nanjing Medical University2022-07-18

        Diseases Most Associated With It

        Open Targets association score, 0 to 1; all associations
        Familial thyroid dyshormonogenesis
        0.71
        Hypothyroidism
        0.60
        Hyperthyroidism
        0.59
        Thyroid gland disorder
        0.56
        Hashimoto thyroiditis
        0.55
        Congenital hypothyroidism
        0.54
        Abnormality of the thyroid gland
        0.53
        Nodular goiter
        0.50
        Autoimmune thyroid disease
        0.48
        Nontoxic goiter
        0.44
        Myxedema
        0.44

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1839, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P07202, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.